210 related articles for article (PubMed ID: 23656859)
1. Increasing intracellular bioavailable copper selectively targets prostate cancer cells.
Cater MA; Pearson HB; Wolyniec K; Klaver P; Bilandzic M; Paterson BM; Bush AI; Humbert PO; La Fontaine S; Donnelly PS; Haupt Y
ACS Chem Biol; 2013 Jul; 8(7):1621-31. PubMed ID: 23656859
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex.
Bica L; Meyerowitz J; Parker SJ; Caragounis A; Du T; Paterson BM; Barnham KJ; Crouch PJ; White AR; Donnelly PS
Biometals; 2011 Feb; 24(1):117-33. PubMed ID: 20931265
[TBL] [Abstract][Full Text] [Related]
3. Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity.
Xiao Z; Donnelly PS; Zimmermann M; Wedd AG
Inorg Chem; 2008 May; 47(10):4338-47. PubMed ID: 18412332
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Crouch PJ; Barnham KJ
Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes.
Price KA; Crouch PJ; Volitakis I; Paterson BM; Lim S; Donnelly PS; White AR
Inorg Chem; 2011 Oct; 50(19):9594-605. PubMed ID: 21882803
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
Parker SJ; Meyerowitz J; James JL; Liddell JR; Nonaka T; Hasegawa M; Kanninen KM; Lim S; Paterson BM; Donnelly PS; Crouch PJ; White AR
PLoS One; 2012; 7(8):e42277. PubMed ID: 22879928
[TBL] [Abstract][Full Text] [Related]
7. Copper(II)-bis(thiosemicarbazonato) complexes as anti-chlamydial agents.
Marsh JW; Djoko KY; McEwan AG; Huston WM
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28830076
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial effects of copper(II) bis(thiosemicarbazonato) complexes provide new insight into their biochemical mode of action.
Djoko KY; Paterson BM; Donnelly PS; McEwan AG
Metallomics; 2014 Apr; 6(4):854-63. PubMed ID: 24435165
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation.
Bica L; Liddell JR; Donnelly PS; Duncan C; Caragounis A; Volitakis I; Paterson BM; Cappai R; Grubman A; Camakaris J; Crouch PJ; White AR
PLoS One; 2014; 9(2):e90070. PubMed ID: 24587210
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm).
Price KA; Crouch PJ; Lim S; Paterson BM; Liddell JR; Donnelly PS; White AR
Metallomics; 2011 Dec; 3(12):1280-90. PubMed ID: 21927768
[TBL] [Abstract][Full Text] [Related]
11. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation of glial cell epidermal growth factor receptor by bis(thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity.
Price KA; Caragounis A; Paterson BM; Filiz G; Volitakis I; Masters CL; Barnham KJ; Donnelly PS; Crouch PJ; White AR
J Med Chem; 2009 Nov; 52(21):6606-20. PubMed ID: 19807095
[TBL] [Abstract][Full Text] [Related]
13. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.
Denoyer D; Pearson HB; Clatworthy SA; Smith ZM; Francis PS; Llanos RM; Volitakis I; Phillips WA; Meggyesy PM; Masaldan S; Cater MA
Oncotarget; 2016 Jun; 7(24):37064-37080. PubMed ID: 27175597
[TBL] [Abstract][Full Text] [Related]
14. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization.
Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR
J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599
[TBL] [Abstract][Full Text] [Related]
15. Copper bis(thiosemicarbazone) complexes modulate P-glycoprotein expression and function in human brain microvascular endothelial cells.
Pyun J; McInnes LE; Donnelly PS; Mawal C; Bush AI; Short JL; Nicolazzo JA
J Neurochem; 2022 Aug; 162(3):226-244. PubMed ID: 35304760
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals.
Maurer RI; Blower PJ; Dilworth JR; Reynolds CA; Zheng Y; Mullen GE
J Med Chem; 2002 Mar; 45(7):1420-31. PubMed ID: 11906283
[TBL] [Abstract][Full Text] [Related]
17. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
Basken NE; Green MA
Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290
[TBL] [Abstract][Full Text] [Related]
18. Copper(II)[2,3-butanedionebis(N4-methylthiosemicarbazone)], a stable superoxide dismutase-like copper complex with high membrane penetrability.
Wada K; Fujibayashi Y; Yokoyama A
Arch Biochem Biophys; 1994 Apr; 310(1):1-5. PubMed ID: 8161192
[TBL] [Abstract][Full Text] [Related]
19. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
Basken NE; Mathias CJ; Lipka AE; Green MA
Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
[TBL] [Abstract][Full Text] [Related]
20. Effect of Structural Modifications to Glyoxal-bis(thiosemicarbazonato)copper(II) Complexes on Cellular Copper Uptake, Copper-Mediated ATP7A Trafficking, and P-Glycoprotein Mediated Efflux.
Acevedo KM; Hayne DJ; McInnes LE; Noor A; Duncan C; Moujalled D; Volitakis I; Rigopoulos A; Barnham KJ; Villemagne VL; White AR; Donnelly PS
J Med Chem; 2018 Feb; 61(3):711-723. PubMed ID: 29232129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
